Bayer submits application in EU for extension of finerenone to include early stages of CKD…
Regulatory submission is based on positive data from the pivotal phase-III FIGARO-DKD study, published in the 'New England Journal…
Sign in
Sign in
Recover your password.
A password will be e-mailed to you.
Browsing Tag
finerenone
Bayer gets US FDA nod for KERENDIA (finerenone) to treat CKD associated with type 2 diabetes
It is a first-in-class nonsteroidal mineralocorticoid receptor antagonist (MRA) indicated to reduce the risk of sustained eGFR…